Conclusions
This study demonstrates the feasibility and safety of intra-arterial SVF cells as a potential therapy for the tubulointerstitial inflammatory ischemic state that characterizes CKDu. A future randomized, controlled study of SVF can offer further valuable insights for the understanding and treatment of this serious clinical problem.